Showing 2821-2830 of 3223 results for "".
- Biotech Healthcare Launches Optiflex TRIO Trifocal IOL in Europehttps://modernod.com/news/biotech-healthcare-launches-optiflex-trio-trifocal-iol/2478350/Switzerland-based Biotech Healthcare has announced the European launch of the Optiflex Trio, a diffractive-refractive trifocal toric IOL designed to treat presbyopia and with astigmatism. Its unique diffraction pattern gives a balanced light distribution at all three distances: near, intermediate
- Bristol, Amgen, Teva CEOs Among Execs to Testify at House Drug Pricing Hearings Next Weekhttps://modernod.com/news/bristol-amgen-teva-ceos-among-execs-to-testify-at-house-drug-pricing-hearings-next-week/2478346/After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry’s largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings at the House Committee on Oversight and Reform, according to
- Early Data Show Regeneron’s Antibody Cocktail Cuts Viral Load, Eases COVID-19 Symptomshttps://modernod.com/news/early-data-show-regenerons-antibody-cocktail-cuts-viral-load-eases-covid-19-symptoms/2478347/Regeneron Pharmaceuticals said Tuesday that adding REGN-COV2 to standard-of-care reduced viral load as well as the time to symptom alleviation in non-hospitalized patients with COVID-19. The company noted that first data from an ongoing adaptive phase 1/2/3 trial of its investigational dual antib
- Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-15512 Eye Drop for Dry Eye Diseasehttps://modernod.com/news/aerie-pharmaceuticals-announces-acceptance-of-its-investigational-new-drug-application-for-ar-15512-eye-drop-for-dry-eye-disease/2478340/Aerie Pharmaceuticals announced that the FDA has reviewed the investigational new drug application (IND) for AR-15512 (TRPM8 agonist) eye drop for dry eye and it is now in effect, allowing Aerie to in
- Fight for Sight and Prevent Blindness Announce Recipient of the 2020 Joanne Angle Public Health Awardhttps://modernod.com/news/fight-for-sight-and-prevent-blindness-announce-recipient-of-the-2020-joanne-angle-public-health-award/2478320/Fight for Sight and Prevent Blindness announced the recipient of the 2020 Joanne Angle Public Health Award as Angela R. Elam, MD, Clinical Assistant Professor, Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. The $25,000 grant was awarded for Dr. Elam’s study, “Engag
- Study Finds Novel Mechanism That May Confer Protection Against Glaucomahttps://modernod.com/news/study-finds-novel-mechanism-that-may-confer-protection-against-glaucoma/2478298/A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associa
- MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Visionhttps://modernod.com/news/metlife-to-acquire-versant-health-owner-of-davis-vision-and-superior-vision/2478292/MetLife announced it has entered into a definitive agreement to acquire Versant Health from an investor group led by Centerbridge Partners and including FFL Partners for approximately $1.675 billion in an all-cash transaction. Versant Health owns the marketplace brands Davis Vision and Superior V
- Santen Acquires Eyevance Pharmaceuticalhttps://modernod.com/news/santen-acquires-eyevance-pharmaceutical/2478289/In a move to enter the US pharmaceuticals market and expand its global presence, Santen announced it has acquired Eyevance Pharmaceutical for $225 million in cash. In the deal, Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, will acquire all of the outstanding shares of Ey
- Medscape US and International Physicians’ COVID-19 Experience Report: Risk, Burnout, Lonelinesshttps://modernod.com/news/medscape-us-and-international-physicians-covid-19-experience-report-risk-burnout-loneliness/2478285/Physicians worldwide have put their physical and mental health at risk as they battled the coronavirus pandemic. In Medscape’s COVID-19 survey, almost 7,500 physicians from the United States, Brazil, France
- Surgical Repair of Chronic Refractory Macular Holes Using AmnioGraft Cryopreserved Amniotic Membranehttps://modernod.com/news/surgical-repair-of-chronic-refractory-macular-holes-using-amniograft-cryopreserved-amniotic-membrane/2478277/Bio-Tissue announced the case series outcome of surgical repair of large macular holes using AmnioGraft Cryopreserved Amniotic Membrane. Results have shown that the placement of AmnioGraft may be a feasible alternative to conventional surgical methods to improve anatomic and visual outcomes.